US Computer-Aided Detection (CAD) Market, By Product Type (Breast CAD, Chest CAD, Abdominal CAD, Prostate CAD, Cardiovascular CAD, Others), By Technology (Mammography, X-Ray Imaging, MRI, Computed Tomography, Ultrasound, Others) - Size, Share, Outlook, an

US Computer-Aided Detection (CAD) Market, By Product Type (Breast CAD, Chest CAD, Abdominal CAD, Prostate CAD, Cardiovascular CAD, Others), By Technology (Mammography, X-Ray Imaging, MRI, Computed Tomography, Ultrasound, Others) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Computer aided detection (CAD) is a technology designed to reduce observational oversights during the diagnosis of harmful lesions. Computer-aided detection (CAD) software utilizes a set of algorithms to identify and detect harmful lesions present in the breast. It is also used for diagnosis of lung cancer, colon cancer, prostate cancer, bone metastases, coronary artery disease, and other diseases. Increasing prevalence of breast cancer is expected to propel growth of the U.S. computer-aided detection (CAD) market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the U.S. Computer-Aided Detection (CAD) market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global U.S. Computer-Aided Detection (CAD) market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, iCAD, Inc., Koninklijke Philips N.V, Hologic, Inc., Carestream Health, Inc., ScreenPoint Medical BV, Siemens AG, GE Healthcare, EDDA Technology, Inc., Qlarity Imaging, and Fujifilm Holdings Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global U.S. Computer-Aided Detection (CAD) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global U.S. Computer-Aided Detection (CAD) market

• U.S. Computer-Aided Detection (CAD) Market, By Product Type:
• Breast CAD
• Chest CAD
• Abdominal CAD
• Prostate CAD
• Cardiovascular CAD
• Others
• U.S. Computer-Aided Detection (CAD) Market, By Technology:
• Mammography
• X-Ray Imaging
• MRI
• Computed Tomography
• Ultrasound
• Others
• Company Profiles
• iCAD, Inc. *
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Koninklijke Philips N.V
• Hologic, Inc.
• Carestream Health, Inc.
• ScreenPoint Medical BV
• Siemens AG
• GE Healthcare
• EDDA Technology, Inc.
• Qlarity Imaging
• Fujifilm Holdings Corporation
• “*” marked represents similar segmentation in other categories in the respective section.